Historical salary details - Dr. Michael Glen Kauffman, M.D.,PhD, Independent Director, Adicet Bio Inc
Dr. Michael Glen Kauffman, M.D.,PhD is the Independent Director of Adicet Bio Inc.
Dr. Michael Glen Kauffman, M.D.,Phd
Independent Director
-
Gross Remuneration
-
Current Company
Adicet Bio Inc
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Adicet Bio Inc | Independent Director | - | - |
| 2023 | Kezar Life Sciences Inc | Independent Director | 155.3 K | 3.2 % |
| 2023 | Verastem Inc | - | 124.3 K | -16.4 % |
| 2022 | Adicet Bio Inc | Independent Director | 182.9 K | -22.1 % |
| 2022 | Kezar Life Sciences Inc | Independent Director | 150.5 K | -4.1 % |
| 2022 | Verastem Inc | Lead Independent Director | 148.7 K | -6.4 % |
| 2022 | Karyopharm Therapeutics Inc | Director | - | - |
| 2021 | Adicet Bio Inc | Independent Director | 234.7 K | - |
| 2021 | Verastem Inc | Lead Independent Director | 158.8 K | 31.8 % |
| 2021 | Kezar Life Sciences Inc | Independent Director | 156.9 K | 73.1 % |
| 2021 | Karyopharm Therapeutics Inc | Director | - | - |
| 2020 | Verastem Inc | Lead Independent Director | 120.5 K | 1.1 % |
| 2020 | Kezar Life Sciences Inc | Independent Director | 90.7 K | -8.8 % |
| 2020 | Infinity Pharmaceuticals Inc. | Independent Director | - | - |
| 2020 | Karyopharm Therapeutics Inc | Chief Executive Officer and Director | - | - |
| 2019 | Verastem Inc | Lead Independent Director | 119.2 K | -42.4 % |
| 2019 | Kezar Life Sciences Inc | Independent Director | 99.4 K | 26.8 % |
| 2019 | Infinity Pharmaceuticals Inc. | Independent Director | 93.9 K | 14.9 % |
| 2019 | Karyopharm Therapeutics Inc | Chief Executive Officer and Director | - | - |
| 2018 | Verastem Inc | Lead Independent Director | 206.8 K | 80.3 % |
| 2018 | Infinity Pharmaceuticals Inc. | Independent Director | 81.8 K | -40.0 % |
| 2018 | Kezar Life Sciences Inc | Independent Director | 78.4 K | -13.6 % |
| 2018 | Karyopharm Therapeutics Inc | Chief Executive Officer and Director | - | - |
| 2017 | Infinity Pharmaceuticals Inc. | Independent Director | 136.3 K | - |
| 2017 | Verastem Inc | Lead Independent Director | 114.7 K | 26.8 % |
| 2017 | Kezar Life Sciences Inc | Independent Director | 90.8 K | - |
| 2017 | Karyopharm Therapeutics Inc | Chief Executive Officer and Director | - | - |
| 2016 | Verastem Inc | Lead Independent Director | 90.5 K | -35.8 % |
| 2016 | Infinity Pharmaceuticals Inc. | Independent Director | - | - |
| 2016 | Karyopharm Therapeutics Inc | Chief Executive Officer and Director | - | - |
| 2015 | Verastem Inc | Independent Director | 140.9 K | -35.5 % |
| 2015 | Karyopharm Therapeutics Inc | Chief Executive Officer and Director | - | - |
| 2014 | Verastem Inc | Independent Director | 218.3 K | 41.3 % |
| 2014 | Karyopharm Therapeutics Inc | Chief Executive Officer and Director | - | - |
| 2013 | Verastem Inc | Independent Director | 154.5 K | 22.7 % |
| 2013 | Karyopharm Therapeutics Inc | Chief Executive Officer and Director | - | - |
| 2012 | Verastem Inc | Independent Director | 125.9 K | - |
| 2012 | Karyopharm Therapeutics Inc | President, Chief Executive Officer, Chief Medical | - | - |